Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Age Groups
7%
Antibiotics
8%
Antioxidant Capacity
14%
Assisted Reproductive Technology
6%
Benign Prostatic Hyperplasia
16%
Cell Count
16%
Cell Phone Use
11%
Computer Assisted Tomography
33%
Cross Sectional Study
19%
Cyst
16%
DNA Damage
100%
DNA Fragmentation
16%
Effect Size
7%
Embryo Development
16%
Erectile Dysfunction
13%
Fluoroscopy
16%
Funnel Plot
11%
Hexachlorophene
16%
Hyperthermia
22%
Leukocyte
36%
Lower Urinary Tract Symptom
16%
Male Fertility
33%
Male Infertility
34%
Male Reproductive Health
33%
Medical Record
16%
Mental Stress
11%
Meta-Analysis
52%
Multivariate Analysis
19%
Obstruction
16%
Pain Assessment
16%
Pathophysiology
6%
Predictive Factor
16%
Prevalence
22%
Prospective Study
7%
Radiological Finding
16%
Random Effects Model
7%
Randomized Controlled Trial
16%
Reactive Oxygen Species
16%
Reactive Oxygen Species
7%
Semen Analysis
9%
Sexual Characteristic
16%
Sperm Motility
6%
Substance Abuse
22%
Systematic Review
34%
Tamsulosin
33%
TUNEL Assay
11%
Ureter
16%
Ureter Stone
66%
Ureteroscopy
33%
Urologist
33%
Nursing and Health Professions
Accident Prevention
16%
Ampicillin
6%
Antibiotic Resistance
16%
Antioxidant Capacity
12%
Confidence Interval
16%
Construct Validity
5%
Cotrimoxazole
6%
Cronbach Alpha Coefficient
5%
Cross-Sectional Survey
19%
Cystitis
16%
Data Processing
19%
Decision-Making
5%
Education
20%
Efficacy
16%
Erectile Dysfunction
5%
Exploratory Factor Analysis
5%
Fluoroscopy
7%
Higher Education
19%
Meta Analysis
33%
Paternal Age
16%
Phosphodiesterase V Inhibitor
50%
Practice Guideline
10%
Prevalence
16%
Reactive Oxygen Metabolite
16%
Reference Value
16%
Saudi Arabia
57%
Self Evaluation
11%
Semen Analysis
18%
Sexual Dysfunction
16%
Social Media
33%
Systematic Review
33%
Teaching Hospital
16%
Urologist
29%
World Health Organization
16%
Pharmacology, Toxicology and Pharmaceutical Science
Ampicillin
6%
Antibiotics
7%
Antimicrobial Resistance
16%
Aztreonam
6%
Cefalotin
6%
Chronic Prostatitis
33%
Cotrimoxazole
6%
Cystitis
16%
Escherichia coli
10%
Medical Prescription
19%
Pelvis Pain Syndrome
33%
Phosphodiesterase V Inhibitor
50%
Prostate Hypertrophy
16%
Randomized Controlled Trial
16%
